für Versicherte der IK Innovationskasse
xCoV (severe course of COVID-19)
Estimated delivery time
Shipping: up to 2 days
In stock
Product Details
xCoV (severe course of COVID-19)
Registration no. DE/CA09/00111194
COVID-19 disease leads to a severe course in one in five patients. Such a severe (possibly fatal) course can only be prevented in the early stages of the infection, as treatments (e.g. with paxlovid or monoclonal antibodies) are only effective then. The dangerous thing: At this stage, you usually have no symptoms and you will only receive treatment if you are at risk of a severe course. To prevent severe COVID-19 progression, take the protexam xCoV test. Determine the severity of your course and take the opportunity to start treatment in good time. Regardless of the virus variant.
- Take a urine sample at home - simple + discreet
- CE-compliant laboratory diagnostics
- High analysis accuracy
- Clinically tested
- Result within one working day of sample receipt
- VAT-exempt according to §4 No.14a UStG
xCoV (severe course of COVID-19)
Display prices in:
EUR